TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive Sept. 9 NCAB Meeting: Varmus: Expect Another CR For Funding The NIH Through Mid-December September 19, 2014